Who Owns Teva Pharmaceutical Industries Stock?
NYSE: TEVAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 41.32 +0.54%
Ownership breakdown
- Held by institutions
- 24.31%
- Held by insiders
- 0.56%
- Institutional holders
- 122
- Institutions 24.3%
- Insiders 0.6%
- Public and other 75.1%
Who owns Teva Pharmaceutical Industries stock?
Institutional investors own about 24.3% of Teva Pharmaceutical Industries's shares, spread across 122 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 0.56% of TEVA.
The largest institutional holders are Blackrock Inc. (5.48%), Harel Insurance Investments & Financial Services Ltd. (4.13%) and Phoenix Financial Ltd. (3.68%). Together, the top 10 institutions control 34.2% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their TEVA positions and 4 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of TEVA
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 63.89M | 5.48% | -1.9% |
| Harel Insurance Investments & Financial Services Ltd. | 48.14M | 4.13% | +4.8% |
| Phoenix Financial Ltd. | 42.93M | 3.68% | +0.4% |
| WCM Investment Management, LLC | 41.32M | 3.55% | +1.2% |
| Clal Insurance Enterprises Holdings Ltd | 40.60M | 3.48% | +5.6% |
| Menora Mivtachim Holdings Ltd. | 39.85M | 3.42% | +0.6% |
| Migdal Insurance & Financial Holdings Ltd. | 38.92M | 3.34% | +2.7% |
| NORGES BANK | 32.30M | 2.77% | -8.2% |
| FMR, LLC | 30.26M | 2.60% | -8.7% |
| Lingotto Investment Management LLP | 20.21M | 1.73% | -27.2% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of TEVA
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund | 17.08M | 1.47% |
| INVESTMENT MANAGERS SERIES TRUST-WCM Focused International Growth Fund | 13.25M | 1.14% |
| VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund | 11.34M | 0.97% |
| New Economy Fund | 9.41M | 0.81% |
| iShares Trust-iShares Core MSCI EAFE ETF | 8.75M | 0.75% |
| Fidelity Concord Street Trust-Fidelity International Index Fund | 4.53M | 0.39% |
| Fidelity Rutland Square TRT II-Strategic Advisers Fidelity Intl Fd. | 4.36M | 0.37% |
| New World Fund Inc | 4.31M | 0.37% |
| iShares Trust-iShares MSCI EAFE ETF | 4.15M | 0.36% |
| BlackRock Funds-BlackRock Health Sciences Opportunities Portfolio | 3.12M | 0.27% |
Frequently asked questions
Who is the largest shareholder of Teva Pharmaceutical Industries?
Blackrock Inc. is the largest institutional shareholder of TEVA, owning 5.48% of shares outstanding (63.89M shares) as of its latest 13F filing.
What percentage of Teva Pharmaceutical Industries is owned by institutions?
Institutions own about 24.3% of TEVA shares and 24.4% of the public float.
How much of Teva Pharmaceutical Industries do insiders own?
Insiders, such as officers and directors, own about 0.56% of TEVA shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.